Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q70987363)
Watch
English
Comparison of salmeterol with disodium cromoglycate in the treatment of adult asthma
scientific article published on 01 February 1996
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8595540
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8595540%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 October 2019
title
Comparison of salmeterol with disodium cromoglycate in the treatment of adult asthma
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8595540
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8595540%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 October 2019
main subject
asthma
1 reference
based on heuristic
inferred from title
author name string
Bousquet J
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8595540
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8595540%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 October 2019
Aubert B
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8595540
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8595540%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 October 2019
Bons J
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8595540
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8595540%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 October 2019
publication date
1 February 1996
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8595540
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8595540%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 October 2019
published in
Annals of Allergy, Asthma & Immunology
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8595540
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8595540%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 October 2019
volume
76
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8595540
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8595540%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 October 2019
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8595540
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8595540%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 October 2019
page(s)
189-194
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8595540
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8595540%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 October 2019
cites work
Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease--a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Salmeterol xinafoate in the treatment of mild to moderate asthma in primary care. UK Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Salmeterol provides prolonged protection against exercise-induced bronchoconstriction in a majority of subjects with mild, stable asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Salmeterol, a new inhaled beta 2-adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Salmeterol protects against hyperventilation-induced bronchoconstriction over 12 hours
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cromolyn sodium is effective in adult chronic asthmatics
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evaluation of the addition of cromolyn sodium to bronchodilator maintenance therapy in the long-term management of asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Are there any detrimental effects of the use of inhaled long-acting beta 2-agonists in the treatment of asthma?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long- versus short-acting beta 2-agonists. Implications for drug therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Regular inhaled beta-agonist treatment in bronchial asthma.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bronchodilator treatment in moderate asthma or chronic bronchitis: continuous or on demand? A randomised controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Airway response to salbutamol: effect of regular salbutamol inhalations in normal, atopic, and asthmatic subjects
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Risks versus benefits of inhaled beta 2-agonists in the management of asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The use of beta-agonists and the risk of death and near death from asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy and safety of salmeterol in childhood asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Nedocromil sodium and sodium cromoglycate in patients aged over 50 years with asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A graded dose assessment of the efficacy of beclomethasone dipropionate aerosol for severe chronic asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of dose-response effects of inhaled beclomethasone dipropionate and budesonide in the management of asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2963421-7
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1081-1206(10)63421-7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8595540
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8595540%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 October 2019
PubMed publication ID
8595540
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8595540
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8595540%20AND%20SRC:MED&resulttype=core&format=json
retrieved
15 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit